[{"address1": "6550 South Millrock Drive", "address2": "Suite G50", "city": "Salt Lake City", "state": "UT", "zip": "84121", "country": "United States", "phone": "801 676 9695", "website": "https://clene.com", "industry": "Packaged Foods", "industryKey": "packaged-foods", "industryDisp": "Packaged Foods", "sector": "Consumer Defensive", "sectorKey": "consumer-defensive", "sectorDisp": "Consumer Defensive", "longBusinessSummary": "Clene Inc., a clinical-stage pharmaceutical company, focuses on the discovery, development, and commercialization of novel clean-surfaced nanotechnology (CSN) therapeutics. Its lead drug candidate is CNM-Au8, which is being studied in various clinical trials, including a completed Phase 2 platform trial to evaluate the safety and efficacy of CNM-Au8 in patients with amyotrophic lateral sclerosis (ALS); completed Phase 2 proof of concept clinical trial in patients with early symptomatic ALS; completed two open-label investigator blinded Phase 2 clinical trials on the brain's energy metabolites; completed Phase 2 clinical trial for the treatment of visual pathway deficits in chronic optic neuropathy for remyelination in stable relapsing Multiple Sclerosis; and a second Phase 2 clinical trial for the treatment of patients with Parkinson's Diseases. The company develops CNM-AgZn17, a gel polymer suspension of silver and zinc ions that is being developed for the treatment of infectious diseases and to support wound healing; and CNM-ZnAg, a broad-spectrum antiviral and antibacterial agent to treat infection disease and to provide immune support for symptom resolution. In addition, it markets and distributes dietary supplements comprising rMetx, an aqueous zinc-silver ion dietary supplement; and KHC46, an aqueous gold dietary supplement of very low-concentration Au nanoparticles. The company is headquartered in Salt Lake City, Utah.", "fullTimeEmployees": 75, "companyOfficers": [{"maxAge": 1, "name": "Mr. Robert  Etherington MBA", "age": 57, "title": "CEO, President & Director", "yearBorn": 1967, "fiscalYear": 2024, "totalPay": 982088, "exercisedValue": 0, "unexercisedValue": 1333}, {"maxAge": 1, "name": "Mr. Morgan R. Brown CPA, M.B.A.", "age": 56, "title": "Chief Financial Officer", "yearBorn": 1968, "fiscalYear": 2024, "totalPay": 593204, "exercisedValue": 0, "unexercisedValue": 533}, {"maxAge": 1, "name": "Mr. Mark G. Mortenson ESQ.", "age": 66, "title": "Chief Science Officer", "yearBorn": 1958, "fiscalYear": 2024, "totalPay": 724057, "exercisedValue": 0, "unexercisedValue": 1333}, {"maxAge": 1, "name": "Mr. Jerry  Miraglia J.D.", "title": "General Counsel & Corporate Secretary", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Mary Anne Mcneil", "title": "Head of Human Resources", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Michael T. Hotchkin", "title": "Chief Development Officer", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Benjamin M. Greenberg M.D., M.H.S.", "title": "Head of Medical", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 2, "previousClose": 6.29, "open": 6.52, "dayLow": 5.66, "dayHigh": 6.55, "regularMarketPreviousClose": 6.29, "regularMarketOpen": 6.52, "regularMarketDayLow": 5.66, "regularMarketDayHigh": 6.55, "payoutRatio": 0.0, "beta": 0.788, "forwardPE": -1.634561, "volume": 416483, "regularMarketVolume": 416483, "averageVolume": 185717, "averageVolume10days": 473900, "averageDailyVolume10Day": 473900, "bid": 6.78, "ask": 6.61, "bidSize": 1, "askSize": 1, "marketCap": 59627064, "fiftyTwoWeekLow": 2.28, "fiftyTwoWeekHigh": 13.5, "allTimeHigh": 356.4, "allTimeLow": 2.28, "priceToSalesTrailing12Months": 278.63113, "fiftyDayAverage": 8.845, "twoHundredDayAverage": 5.20735, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 73014064, "profitMargins": 0.0, "floatShares": 7495442, "sharesOutstanding": 10333980, "sharesShort": 343631, "sharesShortPriorMonth": 270767, "sharesShortPreviousMonthDate": 1760486400, "dateShortInterest": 1763078400, "sharesPercentSharesOut": 0.033299997, "heldPercentInsiders": 0.30047, "heldPercentInstitutions": 0.17951, "shortRatio": 2.84, "shortPercentOfFloat": 0.050100002, "impliedSharesOutstanding": 10333980, "bookValue": -1.209, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1759190400, "netIncomeToCommon": -30496000, "trailingEps": -3.44, "forwardEps": -3.53, "lastSplitFactor": "1:20", "lastSplitDate": 1720656000, "enterpriseToRevenue": 341.187, "enterpriseToEbitda": -3.216, "52WeekChange": 0.32421052, "SandP52WeekChange": 0.13287461, "quoteType": "EQUITY", "currentPrice": 5.77, "targetHighPrice": 48.0, "targetLowPrice": 23.0, "targetMeanPrice": 31.85714, "targetMedianPrice": 30.0, "recommendationMean": 1.14286, "recommendationKey": "strong_buy", "numberOfAnalystOpinions": 7, "totalCash": 7925000, "totalCashPerShare": 0.767, "ebitda": -22703000, "totalDebt": 21312000, "quickRatio": 1.02, "currentRatio": 1.526, "totalRevenue": 214000, "revenuePerShare": 0.023, "returnOnAssets": -0.56243, "grossProfits": 176000, "freeCashflow": -13295375, "operatingCashflow": -18612000, "revenueGrowth": -0.828, "grossMargins": 0.82242996, "ebitdaMargins": 0.0, "operatingMargins": -376.53333, "financialCurrency": "USD", "symbol": "CLNN", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "marketState": "CLOSED", "exchange": "NCM", "messageBoardId": "finmb_339429732", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EST", "gmtOffSetMilliseconds": -18000000, "market": "us_market", "esgPopulated": false, "regularMarketChangePercent": -8.26709, "regularMarketPrice": 5.77, "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1539869400000, "postMarketChangePercent": -1.5597947, "postMarketPrice": 5.68, "postMarketChange": -0.09000015, "regularMarketChange": -0.52, "regularMarketDayRange": "5.66 - 6.55", "fullExchangeName": "NasdaqCM", "averageDailyVolume3Month": 185717, "fiftyTwoWeekLowChange": 3.49, "fiftyTwoWeekLowChangePercent": 1.5307018, "fiftyTwoWeekRange": "2.28 - 13.5", "fiftyTwoWeekHighChange": -7.73, "fiftyTwoWeekHighChangePercent": -0.5725926, "fiftyTwoWeekChangePercent": 32.42105, "earningsTimestampStart": 1755088200, "earningsTimestampEnd": 1755088200, "isEarningsDateEstimate": true, "shortName": "Clene Inc.", "longName": "Clene Inc.", "corporateActions": [], "postMarketTime": 1764982566, "regularMarketTime": 1764968401, "epsTrailingTwelveMonths": -3.44, "epsForward": -3.53, "epsCurrentYear": -2.11, "priceEpsCurrentYear": -2.7345972, "fiftyDayAverageChange": -3.0750003, "fiftyDayAverageChangePercent": -0.34765407, "twoHundredDayAverageChange": 0.5626502, "twoHundredDayAverageChangePercent": 0.10804924, "priceToBook": -4.772539, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "prevName": "Clene Nanomedicine Inc.", "nameChangeDate": "2025-12-05", "averageAnalystRating": "1.1 - Strong Buy", "cryptoTradeable": false, "displayName": "Clene", "trailingPegRatio": null, "__fetch_time": "2025-12-06"}]